Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer
暂无分享,去创建一个
Mohamed Mysara | N. Leys | R. Van Houdt | S. Malhotra-Kumar | Charlotte Segers | Samir Kumar-Singh | Shari Wouters | Lena Van Dingenen
[1] Zhi Peng,et al. Efficacy of fecal microbiota transplantation in patients with anti-PD-1–resistant/refractory gastrointestinal cancers. , 2023, Journal of Clinical Oncology.
[2] Ling Zhao,et al. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer , 2022, Frontiers in Immunology.
[3] S. Lowe,et al. An immunocompetent rectal cancer model to study radiation therapy , 2022, Cell Reports Methods.
[4] K. Takabe,et al. The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer , 2022, Cancers.
[5] Bin Zhou,et al. Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients , 2022, Frontiers in Microbiology.
[6] F. Greten,et al. Image-guided radiotherapy in an orthotopic mouse model of rectal cancer , 2022, STAR protocols.
[7] Jean de la Croix Ndong,et al. Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review , 2022, Clinical and Translational Oncology.
[8] Xu Liu,et al. Radiotherapy combined with immunotherapy: the dawn of cancer treatment , 2022, Signal Transduction and Targeted Therapy.
[9] Yali Liu,et al. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment , 2022, Genom. Proteom. Bioinform..
[10] D. Su,et al. Treatment of Radiation Enteritis With Fecal Transplantation , 2022, The American surgeon.
[11] S. Cho,et al. The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment , 2022, Frontiers in Pharmacology.
[12] A. Awedew,et al. Burden and trend of colorectal cancer in 54 countries of Africa 2010–2019: a systematic examination for Global Burden of Disease , 2022, BMC Gastroenterology.
[13] N. Kamada,et al. Inflammatory bowel disease and carcinogenesis , 2022, Cancer and Metastasis Reviews.
[14] S. Morrow,et al. Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial , 2022, Multiple sclerosis journal - experimental, translational and clinical.
[15] P. Gibbs,et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. , 2022, The Lancet. Oncology.
[16] Jia-Ting Huang,et al. Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer , 2022, bioRxiv.
[17] P. Honnavar,et al. The Association of Microbiome Dysbiosis With Colorectal Cancer , 2022, Cureus.
[18] F. Buettner,et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. , 2022, Cancer cell.
[19] S. Oh,et al. Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer , 2022, The ISME Journal.
[20] Jun Chen,et al. Recent Development of Probiotic Bifidobacteria for Treating Human Diseases , 2021, Frontiers in Bioengineering and Biotechnology.
[21] M. Reberšek. Gut microbiome and its role in colorectal cancer , 2021, BMC Cancer.
[22] J. Rossjohn,et al. Host immunomodulatory lipids created by symbionts from dietary amino acids , 2021, Nature.
[23] Jeffrey W. Clark,et al. Radiation Therapy Enhances Immunotherapy Response in Microsatellite-stable Colorectal and Pancreatic Adenocarcinoma in a Phase II Trial , 2021, Nature Cancer.
[24] Xinxiang Li,et al. Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine. , 2021, The Journal of clinical investigation.
[25] Hongyan Chen,et al. Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study , 2021, Frontiers in Cellular and Infection Microbiology.
[26] E. Van Cutsem,et al. First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] R. Steinert,et al. Vitamins, the gut microbiome and gastrointestinal health in humans. , 2021, Nutrition research.
[28] A. Sorolla,et al. Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities , 2021, Cancers.
[29] I. Macuzic,et al. Mental Health Assessment of Cancer Patients: Prevalence and Predictive Factors of Depression and Anxiety , 2021, Iranian journal of public health.
[30] E. El-Omar,et al. A Perspective on the Role of Microbiome for Colorectal Cancer Treatment , 2021, Cancers.
[31] Xiaoe Chen,et al. Punicic acid ameliorates obesity and liver steatosis by regulating gut microbiota composition in mice. , 2021, Food & function.
[32] Kae Won Cho,et al. Metabolism and function of polyamines in cancer progression. , 2021, Cancer letters.
[33] Mohamed Mysara,et al. Intestinal mucositis precedes dysbiosis in a mouse model for pelvic irradiation , 2021, ISME Communications.
[34] C. Hill,et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics , 2021, Nature Reviews Gastroenterology & Hepatology.
[35] B. Ke,et al. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases , 2021, Frontiers in Immunology.
[36] N. Chhabra,et al. A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors , 2021, Journal of Medical Toxicology.
[37] David A. Drew,et al. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum , 2021, mBio.
[38] J. Wargo,et al. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect , 2021, Cancer Immunology Research.
[39] C. Mackay,et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. , 2021, Cell metabolism.
[40] Prateek Sharma,et al. New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries , 2021, Frontiers in Immunology.
[41] Emily M. Thrash,et al. A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer , 2021, Clinical Cancer Research.
[42] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[43] E. Giovannucci,et al. Role of Diet in Colorectal Cancer Incidence , 2021, JAMA network open.
[44] Y. Yamada,et al. Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer , 2021, Clinical Cancer Research.
[45] J. Yue,et al. Radiotherapy and the gut microbiome: facts and fiction , 2021, Radiation oncology.
[46] Jun Yu,et al. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways , 2020, Gut microbes.
[47] Lanjuan Li,et al. The Intestinal Microbiota and Colorectal Cancer , 2020, Frontiers in Immunology.
[48] W. Curran,et al. Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy , 2020, Journal for ImmunoTherapy of Cancer.
[49] Xingxiang He,et al. Multi-donor multi-course faecal microbiota transplantation relieves the symptoms of chronic hemorrhagic radiation proctitis , 2020, Medicine.
[50] Jun Yu,et al. Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting β-galactosidase. , 2020, Gastroenterology.
[51] S. Gill,et al. Enhancing the efficacy of immunotherapy using radiotherapy , 2020, Clinical & translational immunology.
[52] Farah Ahsan,et al. Role of Vitamin D in Colorectal Cancer: A Holistic Approach and Review of the Clinical Utility , 2020, Cureus.
[53] David T. W. Tzeng,et al. The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer , 2020, Cancer Immunology Research.
[54] K. McCoy,et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy , 2020, Science.
[55] N. Ab Mutalib,et al. Targeting Gut Microbial Biofilms—A Key to Hinder Colon Carcinogenesis? , 2020, Cancers.
[56] Min Wang,et al. New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system. , 2020, European journal of medicinal chemistry.
[57] Sujuan Ding,et al. The Protective Effect of Polyphenols for Colorectal Cancer , 2020, Frontiers in Immunology.
[58] Haresh Kumar Kantilal,et al. The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation , 2020, The Malaysian journal of medical sciences : MJMS.
[59] Trevor C. Charles,et al. Microbiome definition re-visited: old concepts and new challenges , 2020, Microbiome.
[60] A. Basson,et al. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease , 2020, Translational Research.
[61] S. Zheng,et al. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction , 2020, Nature Metabolism.
[62] R. Sleator,et al. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study , 2020, Gut.
[63] S. Umar,et al. Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-Augmented Clinical Trials , 2020, Current Colorectal Cancer Reports.
[64] Qinyan Yang,et al. Streptococcus bovis Contributes to the Development of Colorectal Cancer via Recruiting CD11b+TLR-4+ Cells , 2020, Medical science monitor : international medical journal of experimental and clinical research.
[65] I. Kaur,et al. Delivery routes for faecal microbiota transplants: Available, anticipated and aspired. , 2020, Pharmacological research.
[66] L. Sánchez-Alcoholado,et al. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response , 2020, Cancers.
[67] W. Makarewicz,et al. Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics , 2020, Gut microbes.
[68] E. Elinav,et al. Interaction between microbiota and immunity in health and disease , 2020, Cell Research.
[69] Saijun Fan,et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein , 2020, Microbiome.
[70] Christian M. Metallo,et al. Serine restriction alters sphingolipid diversity to constrain tumor growth , 2020, Nature.
[71] M. Suarez‐Almazor,et al. Immune-related adverse events of checkpoint inhibitors , 2020, Nature Reviews Disease Primers.
[72] J. Pierre,et al. Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity , 2020, Immunological reviews.
[73] Yanni Zhang,et al. Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway , 2020, Frontiers in Microbiology.
[74] Xujun Zhang,et al. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice , 2020, Cell Biology and Toxicology.
[75] A. Melcher,et al. Inflammatory microenvironment remodelling by tumour cells after radiotherapy , 2020, Nature Reviews Cancer.
[76] E. Deutsch,et al. Radiotherapy–immunotherapy combinations – perspectives and challenges , 2020, Molecular oncology.
[77] R. Weichselbaum,et al. Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” , 2020, Clinical Cancer Research.
[78] J. Faith,et al. Fecal IgA Levels Are Determined by Strain-Level Differences in Bacteroides ovatus and Are Modifiable by Gut Microbiota Manipulation. , 2020, Cell host & microbe.
[79] Tomoki Saito,et al. Experimental model for the irradiation-mediated abscopal effect and factors influencing this effect. , 2020, American journal of cancer research.
[80] Saijun Fan,et al. Gut commensal derived-valeric acid protects against radiation injuries , 2020, Gut microbes.
[81] A. Hart,et al. Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease , 2019, Microbiome.
[82] Jingyan Xie,et al. Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model , 2019, Scientific Reports.
[83] T. Spector,et al. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration , 2019, Nutrients.
[84] I. Osman,et al. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients , 2019, Genome Medicine.
[85] Ahmed Moustafa,et al. Effect of radiotherapy on the gut microbiome in pediatric cancer patients: a pilot study , 2019, PeerJ.
[86] M. Wing,et al. Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. , 2019, Methods in molecular biology.
[87] J. Locasale,et al. Methionine metabolism in health and cancer: a nexus of diet and precision medicine , 2019, Nature Reviews Cancer.
[88] Z. Qian,et al. The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management , 2019, Chronic diseases and translational medicine.
[89] G. Coukos,et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance , 2019, Nature Reviews Clinical Oncology.
[90] H. Guan,et al. Impact of Low-dose Ionising Radiation on the Composition of the Gut Microbiota of Mice. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.
[91] S. Turner,et al. Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8+ T Cells. , 2019, Immunity.
[92] D. Dearnaley,et al. Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy , 2019, Clinical Cancer Research.
[93] Jun Yu,et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity , 2019, Nature Microbiology.
[94] D. Hsu,et al. Dietary methionine links nutrition and metabolism to the efficacy of cancer therapies , 2019, Nature.
[95] R. Boidot,et al. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination , 2019, Journal of Immunotherapy for Cancer.
[96] Junling Zhang,et al. Total body irradiation induced mouse small intestine senescence as a late effect , 2019, Journal of radiation research.
[97] M. Wasson,et al. Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases , 2019, International journal of molecular sciences.
[98] E. Ruppin,et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5−/− mice , 2019, Nature Communications.
[99] S. Baatout,et al. Food Supplements to Mitigate Detrimental Effects of Pelvic Radiotherapy , 2019, Microorganisms.
[100] Xia Wang,et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy , 2019, Journal of cellular and molecular medicine.
[101] Z. Stadler,et al. Immunotherapy in colorectal cancer: rationale, challenges and potential , 2019, Nature Reviews Gastroenterology & Hepatology.
[102] Jaw-Yuan Wang,et al. Fecal microbiota transplantation: Review and update. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.
[103] D. Plichta,et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity , 2019, Nature.
[104] Bangmao Wang,et al. Fecal microbiota transplantation in cancer management: Current status and perspectives , 2018, International journal of cancer.
[105] F. Gaiani,et al. Microsatellite instability in colorectal cancer , 2018, Acta bio-medica : Atenei Parmensis.
[106] D. Ramai,et al. Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness , 2018, Annals of gastroenterology.
[107] B. Helmink,et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis , 2018, Nature Medicine.
[108] E. Liu,et al. Mouse Models for Cancer Immunotherapy Research. , 2018, Cancer discovery.
[109] Evgeni Levin,et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography , 2018, Nature Medicine.
[110] Hai-juan Wang,et al. Biological effects of radiation on cancer cells , 2018, Military Medical Research.
[111] A. Taddei,et al. The controversial role of Enterococcus faecalis in colorectal cancer , 2018, Therapeutic advances in gastroenterology.
[112] T. Wassenaar. E. coli and colorectal cancer: a complex relationship that deserves a critical mindset , 2018, Critical reviews in microbiology.
[113] Michael B. Mundy,et al. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers , 2018, Genome Medicine.
[114] J. Delisle,et al. TGF-β in T Cell Biology: Implications for Cancer Immunotherapy , 2018, Cancers.
[115] Jian Yu,et al. Immunogenic effects of chemotherapy-induced tumor cell death , 2018, Genes & diseases.
[116] Yan-Qin Shen,et al. Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease , 2018, Ageing Research Reviews.
[117] J. Wargo,et al. The gut microbiota influences anticancer immunosurveillance and general health , 2018, Nature Reviews Clinical Oncology.
[118] A. Beauchet,et al. Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients , 2018, Oncoimmunology.
[119] Alberto Martin,et al. The Impact of the Gut Microbiome on Colorectal Cancer , 2018 .
[120] G. Bhanot,et al. Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer. , 2018, Journal of the National Cancer Institute.
[121] B. Comin-Anduix,et al. Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer , 2018, Clinical Cancer Research.
[122] J. Hesser,et al. Using immunotherapy to boost the abscopal effect , 2018, Nature Reviews Cancer.
[123] Y. Naito,et al. Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.
[124] E. Le Chatelier,et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients , 2018, Science.
[125] Riyue Bao,et al. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients , 2018, Science.
[126] Laurence Zitvogel,et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors , 2018, Science.
[127] Mark M. Davis,et al. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade , 2017, Proceedings of the National Academy of Sciences.
[128] Donna Neuberg,et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.
[129] I. Melero,et al. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[130] Jun Yu,et al. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. , 2017, Gastroenterology.
[131] R. Fietkau,et al. Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases , 2017, Immunological reviews.
[132] C. Belka,et al. Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences , 2017, Immunological reviews.
[133] Mong-Hong Lee,et al. Dysbiosis of gut microbiota in promoting the development of colorectal cancer , 2017, Gastroenterology report.
[134] N. Gekara. DNA damage-induced immune response: Micronuclei provide key platform , 2017, The Journal of cell biology.
[135] N. Meyer,et al. Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination , 2017, Melanoma research.
[136] Manisha Bhatia,et al. Gut microbiota’s effect on mental health: The gut-brain axis , 2017, Clinics and practice.
[137] J. Desai,et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. , 2017, The Lancet. Oncology.
[138] I. Melero,et al. Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies. , 2017, Brachytherapy.
[139] M. Hattori,et al. Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice. , 2017, Cell reports.
[140] Ludmila V. Danilova,et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.
[141] Fangfang Guo,et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.
[142] S. Demaria,et al. Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers , 2017, Clinical Cancer Research.
[143] G. Reid,et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics , 2017, Nature Reviews Gastroenterology &Hepatology.
[144] A. Eggermont,et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[145] L. Zitvogel,et al. Anticancer effects of the microbiome and its products , 2017, Nature Reviews Microbiology.
[146] Eleanor J. Cheadle,et al. Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade , 2017, Clinical Cancer Research.
[147] J. Bornstein,et al. Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches. , 2017, Current medicinal chemistry.
[148] R. Kapila,et al. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals , 2017, Nutrition reviews.
[149] C. Drake,et al. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment , 2017, Cancer Immunology Research.
[150] Y. Kashi,et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction , 2017, Gut.
[151] O. Sansom,et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation , 2017, Nature.
[152] W. Liao,et al. Influence of diet on the gut microbiome and implications for human health , 2017, Journal of Translational Medicine.
[153] C. Danjoux,et al. Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).
[154] M. Kamm,et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial , 2017, The Lancet.
[155] Junling Zhang,et al. Faecal microbiota transplantation protects against radiation‐induced toxicity , 2017, EMBO molecular medicine.
[156] R. Neves,et al. Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone , 2017, Cancer biology & therapy.
[157] Elena Cerrada,et al. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer , 2017, International journal of molecular sciences.
[158] M. Moreau,et al. Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study , 2016, Physics in medicine and biology.
[159] Ning Li,et al. Treatment of Slow Transit Constipation With Fecal Microbiota Transplantation: A Pilot Study , 2016, Journal of clinical gastroenterology.
[160] T. Dinan,et al. Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals , 2016, Trends in Neurosciences.
[161] Saijun Fan,et al. Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity , 2016, International journal of molecular sciences.
[162] M. McCarter,et al. Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties. , 2016, Cell host & microbe.
[163] Tytus D. Mak,et al. An Integrated Multi-Omic Approach to Assess Radiation Injury on the Host-Microbiome Axis , 2016, Radiation Research.
[164] T. Schmid,et al. Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma , 2016, Cancer Immunology Research.
[165] P. Lambin,et al. Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response , 2016, PloS one.
[166] E. Ben-Josef,et al. Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma , 2016, Clinical Cancer Research.
[167] B. Fox,et al. Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy , 2016, PloS one.
[168] C. Hajdu,et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. , 2016, Gastroenterology.
[169] J. Debus,et al. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives , 2016, Visceral Medicine.
[170] Atsushi Mizoguchi,et al. Current Understanding of Dysbiosis in Disease in Human and Animal Models , 2016, Inflammatory bowel diseases.
[171] J. Galon,et al. Frameshift mutations, neoantigens and tumor-specific CD8+ T cells in microsatellite unstable colorectal cancers , 2016, Oncoimmunology.
[172] H. Prakash,et al. Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma. , 2016, Carcinogenesis.
[173] C. Goergen,et al. Chronically Elevated Levels of Short-Chain Fatty Acids Induce T Cell–Mediated Ureteritis and Hydronephrosis , 2016, The Journal of Immunology.
[174] C. Huttenhower,et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis , 2016, Nature Communications.
[175] P. Jeggo,et al. DNA repair, genome stability and cancer: a historical perspective , 2015, Nature Reviews Cancer.
[176] G. Cresci,et al. Gut Microbiome: What We Do and Don't Know. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[177] C. Romano,et al. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis , 2015, Front. Immunol..
[178] D. Fan,et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis , 2015, Journal of Translational Medicine.
[179] Mingyang Song,et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.
[180] R. Talukdar,et al. Role of the normal gut microbiota. , 2015, World journal of gastroenterology.
[181] T. Borody,et al. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals , 2015, Journal of clinical gastroenterology.
[182] S. Demaria,et al. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. , 2015, The Lancet. Oncology.
[183] Li Li,et al. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat , 2015, BMC Genomics.
[184] Michael A. Fischbach,et al. A biosynthetic pathway for a prominent class of microbiota-derived bile acids , 2015, Nature chemical biology.
[185] Caroline H. Johnson,et al. Metabolism links bacterial biofilms and colon carcinogenesis. , 2015, Cell metabolism.
[186] J. Zavadil,et al. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. , 2015, Cancer research.
[187] Jinu Kim,et al. High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. , 2015, Anaerobe.
[188] L. Zitvogel,et al. Type I interferons in anticancer immunity , 2015, Nature Reviews Immunology.
[189] T. Cheng,et al. Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study , 2015, PloS one.
[190] Qiang Feng,et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence , 2015, Nature Communications.
[191] H. Ishwaran,et al. Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.
[192] K. Kinzler,et al. Microbiota organization is a distinct feature of proximal colorectal cancers , 2014, Proceedings of the National Academy of Sciences.
[193] I. Stratford,et al. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. , 2014, Cancer research.
[194] F. Guarner,et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014, Nature Reviews Gastroenterology &Hepatology.
[195] M. Hauer-Jensen,et al. Radiation enteropathy—pathogenesis, treatment and prevention , 2014, Nature Reviews Gastroenterology &Hepatology.
[196] K. Walczak,et al. Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways , 2014, Amino Acids.
[197] M. Mellow,et al. Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients , 2014, The American Journal of Gastroenterology.
[198] Hermann Brenner,et al. Colorectal cancer , 2014, The Lancet.
[199] P. Ascierto,et al. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy , 2014, Oncoimmunology.
[200] Zhijian J. Chen,et al. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. , 2014, Molecular cell.
[201] S. Dasgupta,et al. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. , 2014, Cell host & microbe.
[202] M. Toyota,et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.
[203] R. Weichselbaum,et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. , 2014, The Journal of clinical investigation.
[204] Soldano Ferrone,et al. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing , 2013, OncoTarget.
[205] H. Kim,et al. Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing , 2013, PloS one.
[206] K. Schäkel,et al. Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. , 2013, Cancer cell.
[207] Martin P. Keough,et al. Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment , 2013, Cancer Immunology Research.
[208] H. Kohrt,et al. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor , 2013, Proceedings of the National Academy of Sciences.
[209] K. Toutouzas,et al. Procalcitonin in patients with colorectal cancer. , 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[210] Stephen Mok,et al. CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. , 2013, Cancer research.
[211] A. Amiot,et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? , 2013, Therapeutic advances in gastroenterology.
[212] Laurence Zitvogel,et al. Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.
[213] Yongzhi Yang,et al. Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies , 2013, PloS one.
[214] F. Guarner,et al. Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial. , 2012, Nutricion hospitalaria.
[215] F. Bull,et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. , 2012, Journal of the National Cancer Institute.
[216] J. Gordon,et al. Diversity, stability and resilience of the human gut microbiota , 2012, Nature.
[217] L. Peyrin-Biroulet,et al. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[218] J. Cuzick,et al. Aspirin and cancer risk: a quantitative review to 2011. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[219] Mohamad Amin Pourhoseingholi,et al. Increased burden of colorectal cancer in Asia. , 2012, World journal of gastrointestinal oncology.
[220] E. Giovannucci,et al. The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancer , 2012, International journal of cancer.
[221] Ying Jiang,et al. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies , 2011, European Journal of Epidemiology.
[222] K. Straif,et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[223] H. Nagawa,et al. Intratumoral injection of interleukin‐2 augments the local and abscopal effects of radiotherapy in murine rectal cancer , 2011, Cancer science.
[224] W. Verstraete,et al. Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines. , 2011, Environmental microbiology.
[225] R. Lau,et al. Red and Processed Meat and Colorectal Cancer Incidence: Meta-Analysis of Prospective Studies , 2011, PloS one.
[226] Y. Kuwahara,et al. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy , 2011, Cell Death and Disease.
[227] F. Sinicrope,et al. Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer. , 2011, Future oncology.
[228] Matej Horvat,et al. Microsatellite instability in colorectal cancer , 2011, Radiology and oncology.
[229] H. Brenner,et al. Protection From Colorectal Cancer After Colonoscopy , 2011, Annals of Internal Medicine.
[230] John E. Scott,et al. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.
[231] Dong-Guk Park,et al. Effects of DCA on Cell Cycle Proteins in Colonocytes , 2010, Journal of the Korean Society of Coloproctology.
[232] B. Shin,et al. Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells. , 2010, Cancer letters.
[233] David P. Taylor,et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. , 2010, Gastroenterology.
[234] L. Zitvogel,et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. , 2010, Cancer research.
[235] A. Jemal,et al. Worldwide Variations in Colorectal Cancer , 2009, CA: a cancer journal for clinicians.
[236] J. Tschopp,et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.
[237] N. Kawashima,et al. Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.
[238] J. Alsner,et al. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[239] C. Manichanh,et al. The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea , 2008, The American Journal of Gastroenterology.
[240] L. Marton,et al. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases , 2007, Nature reviews. Drug discovery.
[241] J. Galon,et al. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. , 2007, Cancer research.
[242] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[243] J. Gordon,et al. Microbial regulation of intestinal radiosensitivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[244] N. Kawashima,et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[245] C. Gabel,et al. ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1β and IL-18 in Human Blood , 2000, The Journal of Immunology.
[246] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[247] Bentzen,et al. Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.
[248] L. Cuzzolin,et al. Influence of radiotherapy on intestinal microflora in cancer patients. , 1992, Journal of chemotherapy.
[249] Mole Rh. Whole body irradiation; radiobiology or medicine? , 1953 .
[250] M. Tuğlu,et al. Punicic Acid Inhibits Glioblastoma Migration and Proliferation Via the PI3K/AKT1/mTOR Signaling Pathway. , 2019, Anti-cancer agents in medicinal chemistry.
[251] A. Garg,et al. Type I interferons and dendritic cells in cancer immunotherapy. , 2019, International review of cell and molecular biology.
[252] E. Golden,et al. Radiotherapy and immunogenic cell death. , 2015, Seminars in radiation oncology.
[253] E. Kuipers,et al. Colorectal cancer , 2015, Nature Reviews Disease Primers.
[254] J. Lampe,et al. Gut microbes, diet, and cancer. , 2014, Cancer treatment and research.
[255] R. Berg. Bacterial translocation from the gastrointestinal tract. , 1992, Journal of medicine.
[256] R. Mole. Whole body irradiation; radiobiology or medicine? , 1953, The British journal of radiology.
[257] Anil Kumar,et al. World Journal of Gastrointestinal Surgery , 2022 .